nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.16	0.18	CbGbCtD
Theobromine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.144	0.161	CbGbCtD
Theobromine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.135	0.152	CbGbCtD
Theobromine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.135	0.152	CbGbCtD
Theobromine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.122	0.137	CbGbCtD
Theobromine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.102	0.115	CbGbCtD
Theobromine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0925	0.104	CbGbCtD
Theobromine—ADORA1—nerve—acquired immunodeficiency syndrome	0.011	0.128	CbGeAlD
Theobromine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00377	0.0439	CbGeAlD
Theobromine—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00375	0.0436	CbGeAlD
Theobromine—ADORA2A—blood—acquired immunodeficiency syndrome	0.00353	0.041	CbGeAlD
Theobromine—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.0034	0.0395	CbGeAlD
Theobromine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.0034	0.0395	CbGeAlD
Theobromine—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.00293	0.0341	CbGeAlD
Theobromine—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.00286	0.0333	CbGeAlD
Theobromine—ADORA1—vagina—acquired immunodeficiency syndrome	0.00282	0.0328	CbGeAlD
Theobromine—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.00276	0.032	CbGeAlD
Theobromine—ADORA1—lung—acquired immunodeficiency syndrome	0.00267	0.031	CbGeAlD
Theobromine—ADORA1—nervous system—acquired immunodeficiency syndrome	0.00247	0.0287	CbGeAlD
Theobromine—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00239	0.0278	CbGeAlD
Theobromine—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.00238	0.0277	CbGeAlD
Theobromine—PDE4B—blood—acquired immunodeficiency syndrome	0.00225	0.0262	CbGeAlD
Theobromine—ADORA2A—brain—acquired immunodeficiency syndrome	0.00219	0.0254	CbGeAlD
Theobromine—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.00218	0.0253	CbGeAlD
Theobromine—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.00217	0.0252	CbGeAlD
Theobromine—PDE4B—vagina—acquired immunodeficiency syndrome	0.00209	0.0243	CbGeAlD
Theobromine—PDE4B—lung—acquired immunodeficiency syndrome	0.00197	0.023	CbGeAlD
Theobromine—ADORA1—brain—acquired immunodeficiency syndrome	0.00189	0.022	CbGeAlD
Theobromine—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00183	0.0213	CbGeAlD
Theobromine—ADORA1—lymph node—acquired immunodeficiency syndrome	0.00182	0.0212	CbGeAlD
Theobromine—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00176	0.0205	CbGeAlD
Theobromine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00145	0.0169	CbGeAlD
Theobromine—PDE4B—brain—acquired immunodeficiency syndrome	0.0014	0.0162	CbGeAlD
Theobromine—CYP1A2—blood—acquired immunodeficiency syndrome	0.00138	0.0161	CbGeAlD
Theobromine—PDE4B—lymph node—acquired immunodeficiency syndrome	0.00135	0.0157	CbGeAlD
Theobromine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00132	0.0154	CbGeAlD
Theobromine—ADORA1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00132	0.0557	CbGpPWpGaD
Theobromine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.00131	0.0152	CbGeAlD
Theobromine—CYP2E1—blood—acquired immunodeficiency syndrome	0.00124	0.0145	CbGeAlD
Theobromine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00121	0.0141	CbGeAlD
Theobromine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.0012	0.0139	CbGeAlD
Theobromine—CYP2E1—lung—acquired immunodeficiency syndrome	0.00109	0.0127	CbGeAlD
Theobromine—ADORA2A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00102	0.043	CbGpPWpGaD
Theobromine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.00101	0.0117	CbGeAlD
Theobromine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000972	0.0113	CbGeAlD
Theobromine—ADORA2A—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000883	0.0372	CbGpPWpGaD
Theobromine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000772	0.00898	CbGeAlD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000702	0.0296	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.00064	0.027	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000542	0.0229	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000535	0.0226	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000425	0.0179	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000413	0.0174	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000385	0.0162	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000328	0.0139	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000324	0.0137	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000318	0.0134	CbGpPWpGaD
Theobromine—ADORA2A—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000309	0.013	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000299	0.0126	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000297	0.0125	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000293	0.0124	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000281	0.0119	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000281	0.0119	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000277	0.0117	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000274	0.0116	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000271	0.0114	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000263	0.0111	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000261	0.011	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00025	0.0106	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000238	0.01	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000226	0.00954	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000224	0.00943	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000224	0.00943	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000214	0.00904	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000214	0.00902	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000212	0.00894	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000203	0.00856	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000201	0.00849	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0002	0.00844	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000193	0.00813	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000184	0.00774	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000181	0.00763	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000179	0.00754	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000173	0.00728	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000173	0.00728	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00017	0.00718	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00017	0.00718	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00017	0.00717	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000166	0.00701	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000164	0.00693	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000162	0.00684	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00016	0.00676	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000155	0.00652	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000153	0.00646	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00015	0.00634	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000149	0.00627	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00014	0.00589	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000138	0.00582	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000131	0.00554	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000131	0.00554	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000131	0.00554	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000129	0.00546	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000128	0.00541	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000125	0.00528	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000118	0.00499	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000117	0.00492	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000116	0.0049	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000103	0.00433	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000102	0.00431	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000102	0.00428	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000101	0.00426	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.0001	0.00422	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	9.9e-05	0.00417	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.82e-05	0.00414	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.82e-05	0.00414	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.71e-05	0.00409	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.71e-05	0.00409	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.62e-05	0.00406	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.62e-05	0.00406	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.5e-05	0.00401	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.5e-05	0.00401	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.29e-05	0.00392	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.18e-05	0.00387	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	9.02e-05	0.0038	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	9.01e-05	0.0038	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.88e-05	0.00375	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	8.79e-05	0.00371	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.78e-05	0.0037	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.73e-05	0.00368	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.73e-05	0.00368	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.63e-05	0.00364	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.63e-05	0.00364	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.93e-05	0.00335	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.9e-05	0.00333	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.58e-05	0.0032	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.58e-05	0.0032	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.43e-05	0.00313	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.43e-05	0.00313	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	7.41e-05	0.00313	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.32e-05	0.00309	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.23e-05	0.00305	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.21e-05	0.00304	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.17e-05	0.00303	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.12e-05	0.003	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.07e-05	0.00298	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.86e-05	0.00289	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.74e-05	0.00284	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.74e-05	0.00284	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.64e-05	0.0028	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.59e-05	0.00278	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.57e-05	0.00277	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.55e-05	0.00276	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.51e-05	0.00275	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.47e-05	0.00273	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.41e-05	0.0027	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	6.41e-05	0.0027	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	6.16e-05	0.0026	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.07e-05	0.00256	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6e-05	0.00253	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.99e-05	0.00252	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.92e-05	0.00249	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.72e-05	0.00241	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.65e-05	0.00238	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	5.61e-05	0.00237	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.56e-05	0.00235	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.49e-05	0.00231	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.42e-05	0.00229	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.24e-05	0.00221	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.16e-05	0.00218	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.16e-05	0.00218	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.13e-05	0.00216	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.1e-05	0.00215	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.1e-05	0.00215	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.09e-05	0.00215	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.05e-05	0.00213	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.69e-05	0.00198	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.62e-05	0.00195	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	4.32e-05	0.00182	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.24e-05	0.00179	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.98e-05	0.00168	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.98e-05	0.00168	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.93e-05	0.00166	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.88e-05	0.00164	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.87e-05	0.00163	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.82e-05	0.00161	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.81e-05	0.00161	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.76e-05	0.00159	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.7e-05	0.00156	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.54e-05	0.00149	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.49e-05	0.00147	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.46e-05	0.00146	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.42e-05	0.00144	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.15e-05	0.00133	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.03e-05	0.00128	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.99e-05	0.00126	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.94e-05	0.00124	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.73e-05	0.00115	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.67e-05	0.00113	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.04e-05	0.000862	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.03e-05	0.000857	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.02e-05	0.000852	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.01e-05	0.000847	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000665	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000662	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.45e-05	0.000612	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.2e-05	0.000507	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000501	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	1.07e-05	0.000453	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.27e-06	0.000391	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	6.46e-06	0.000272	CbGpPWpGaD
